MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Exploring anti-hypertensives as possible disease modifying agents in Parkinson’s disease using artificial intelligence and epidemiology

    N. Visanji, S. Hensley Alford, A. Lacoste, P. Madan, I. Buleje, Y. Han, S. Spangler, L. Kalia, C. Marras (Toronto, ON, Canada)

    Objective: To apply machine learning and epidemiology to identify existing drugs that may have a disease modifying effect in Parkinson’s disease (PD). Background: Drug repurposing…
  • 2019 International Congress

    Ataxia with(out) oculomotor apraxia: A unique SETX mutation in 3 siblings

    P. Khemani, A. Kuhlman, B. Bulica, N. Patel (Seattle, WA, USA)

    Objective: Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive cerebellar ataxia due to SETX gene mutation characterized by progressive cerebellar atrophy,  neuropathy,…
  • 2019 International Congress

    Evolution of ataxia in risk persons for spinocerebellar ataxia (SCA)

    H. Jacobi, S. Tezenas Dumontcel, T. Klockgether, O. The-Risca-Investigators (Bonn, Germany)

    Objective: To study the premanifest stage of the most common SCAs. Specifically, we wanted to determine the conversion rate to ataxia in risk persons and…
  • 2019 International Congress

    A case of cerebellar ataxia caused by Pembrolizumab for Non-small cell lung cancer

    T. Moto, H. Nagayama, K. Kimura (Tokyo, Japan)

    Objective: We reported a case that cerebellar ataxia and decreased accumulation of right cerebellum at SPECT appeared after immunotherapy using immune-checkpoint inhibitor “Pembrolizumab” for Non-small…
  • 2019 International Congress

    Inpatient vs outpatient workup of patients with ataxia and suspected paraneoplastic cerebellar degeneration: Does work-up location matter?

    N. Witek, M. Afshari, Y. Liu, B. Ouyang, D. Hall (Chicago, IL, USA)

    Objective: To assess the outcomes of patients with ataxia evaluated for paraneoplastic syndrome primarily in an outpatient or inpatient setting. Background: Although paraneoplastic ataxias are…
  • 2019 International Congress

    Hemichorea revealing a putaminal cavernous angioma

    Y. Mecheri, F. Serradj, BS. Fekraoui, A. Hamri (Constantine, Algeria)

    Objective: Reporting an exceptional case of progrssive hemichorea revealing a putaminal cavernous angioma Background: Hemichorea is a rare movement disorder (MD) (0.7% of all MD)…
  • 2019 International Congress

    Generalised Polymyoclonus In a Patient With Central Nervous System Tuberculosis

    K. Shahedah, MS. Mohamad Salmi (Pahang, Malaysia)

    Objective: Myoclonus associated with tuberculosis or following an infectious event is a transient event with an abrupt onset. It is a rare phenomenon and often…
  • 2019 International Congress

    Quercetin Regulates Cadmium Induced Motor Dysfunction in Depletion of Dopamine and its Metabolites at Synapse

    R. Gupta, RK. Shukla, AB. Pant, VK. Khanna (Lucknow, India)

    Objective: The present study has an attempt to understand cadmium induced alteration in dopamine and associated signaling that causes the motor alterations in rats and…
  • 2019 International Congress

    Chlorogenic acid attenuates the MPTP induced apoptosis in Parkinson’s disease mouse model through pAkt signaling pathway

    S. Singh, S. Singh (Varanasi, India)

    Objective: This study deals to investigate and explore the anti-apoptotic and molecular mechanisms of CGA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinsonian mice model. Background: The debilitating…
  • 2019 International Congress

    Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease

    M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)

    Objective: To find out the prevalence of different defence mechanism and coping strategies in the patients with PD.To find out the relationship between using of…
  • « Previous Page
  • 1
  • …
  • 211
  • 212
  • 213
  • 214
  • 215
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley